Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Caliente apuestas en México

Las caliente apuestas son aquellas que gozan de gran popularidad y de la calidad suficiente para seguir siéndolo durante años. En Space Casino , hay cientos de caliente apuestas, además de las de casino y deportes en vivo, sin mencionar las de deportes virtuales y esports. Con tantas tragamondeas disponibles, encontrar las caliente apueatas no es fácil, así que hemos reunido unas cuantas palabras sobre el tema, con consejos sobre qué

Billerud's board announces that CEO Christoph Michalski is leaving

Billerud's board announces that the company's President and CEO Christoph Michalski is leaving the CEO role at Billerud, with immediate effect. Michalski has held the position of CEO since November 2020.The board of Billerud has appointed the current CFO and deputy CEO, Ivar Vatne, as acting CEO. Ivar Vatne joined the company as CFO in May 2019 and has also been deputy CEO since October 2022. Before Billerud, Ivar has a background from senior positions within Arla, Fiskars and P&G. “The board is confident that Ivar Vatne can quickly step into the role of acting CEO and that he can lead

Securitas AB Interim Report Q2 2023 | January–June 2023

April-June 2023 · Total sales MSEK 39 909 (30 535) · Organic sales growth 11 percent (6) · Operating income before amortization MSEK 2 620 (1 760) · Operating margin 6.6 percent (5.8) · Items affecting comparability (IAC) MSEK –311 (–226), relating to the previously announced transformation programs and the acquisition of STANLEY Security  · Earnings per share before and after dilution SEK 2.05 (2.32)* · Earnings per share before and after dilution, before IAC, SEK 2.46 (2.77)* · Cash flow from operating activities 46 percent (53) January-June 2023 · Total

NoHo Partners Plc's Q1–Q2 2023 Half Year Financial Report briefing on 8 August 2023 at 10 EET at Friends & Brgrs Aikatalo

NoHo Partners Plc INVESTOR NEWS 28 JULY 2023 AT 13:00 EET   NoHo Partners Plc publishes its Half Year Financial Report for January–June 2023 on Tuesday 8 August 2023 approximately at 8:00 EET, after which it will be available at www.noho.fi/en. A briefing for the media, analysts and investors will be organized on the same day at 10:00 EET at Friends & Brgrs Aikatalo (Mikonkatu 8, 2nd floor, 00100 Helsinki). At the event, NoHo Partners’ CEO Aku Vikström will present the company’s financial performance, key events, the current state of business and the outlook. The briefing

The Swedish iconic artist Petra Marklund releases this year's Pride song - "Ocean of Love"

The song marks a musical comeback, and it's the first time Petra presents her new material both as herself and under her iconic artist aliases "September".  "Ocean Of Love." is her first English-language song in a whole decade.This year marks 20 years since the artist September explosively entered the international music scene with hit songs like "La la la (never give it up)" and "Cry for You." She captivated audiences worldwide with her energetic dance music and powerful vocals. Over the past decade, Petra Marklund has been writing and releasing music under her own name – exploring her

Changes to incentive program 2023/2026

Due to the changes in Evolution’s share price during the implementation period of the incentive program resolved on by the extraordinary general meeting on 16 June 2023, the program is no longer in line with the intended conditions of the proposal to the extraordinary general meeting. The Board of Directors has thus decided to not proceed with the incentive program. The Board of Directors will work together with the shareholders to create a program in order to appropriately incentivize the employees of the company.

Elos Medtech acquires Klingel Medical through a guaranteed rights issue

Creating a leading European MedTech CDMO with the combination of Elos Medtech and Klingel Elos Medtech AB (publ) (“Elos Medtech”), a leading development and manufacturing partner for medical devices, today entered into an agreement to acquire Klingel Holding GmbH (“Klingel Medical Group” or “Klingel”) from IK Partners and management. Klingel, a leading contract development and manufacturing organization (CDMO) headquartered in Germany, will strengthen Elos Medtech’s position with extraordinary R&D capabilities and new technology expertise. Further, the acquisition will broaden the

Invitation to a Press Conference on Bittium Corporation’s Half-Year Financial Report January-June 2023

Bittium CorporationPress Release Invitation to a Press Conference on Bittium Corporation’s Half-Year Financial Report January-June 2023 Bittium Corporation, Press Release, July 28, 2023, at 10:00 am (CEST+1) Bittium Corporation’s Half-Year Financial Report January-June 2023 will be published on Friday, August 4, 2023, at 8.00 am (CEST+1). The release will be available on company’s website www.bittium.com immediately after the publication. Bittium will hold a webcast for media, analysts and institutional investors on Friday, August 4, 2023, at 9.00 am (CEST+1). The webcast will

Sotkamo Silver Half-Year Financial Report Q2/2023: Improved profitability by enhanced operational efficiency and higher silver grade

Sotkamo Silver AB, Half-Year Financial Report, 28 July 2023 at 9.45 (EEST) / 08.45 (CET) Sotkamo Silver Half-Year Financial Report Q2/2023: Improved profitability by enhanced operational efficiency and higher silver grade   HIGHLIGHTS April – June (Q2) · Net sales increased by 33 % to 120 MSEK (90 MSEK), driven mainly by a higher average silver grade and positive development of silver price · EBITDA increased by 721 % to 53 MSEK (6), EBITDA margin increased to 44 % (7) · EBIT increased to 34 MSEK (-16) · Profitability increased significantly driven by a higher

Deutsche Börse AG extends offer period for a second time

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.With reference to SimCorp A/S' (SimCorp or the Company) announcement of 25 May 2023 (no. 11/2023) regarding the publication of the offer document (the Offer Document) concerning the all-cash voluntary recommended public takeover offer to acquire all of the issued and outstanding shares (except treasury shares) in SimCorp made by Deutsche Börse AG (Deutsche Börse) and SimCorp's announcement of 7

Symrise announces the outcome of the mandatory public offer to the shareholders of Swedencare

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, any jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of the Offer would contravene applicable laws or regulations or require further registration documents, filings or other measures in addition to those required under Swedish law. Press release28 July 2023On 5 June 2023, Symrise AG (“Symrise”) announced a mandatory public offer to the

Esmaeilzadeh Holding publishes interim report for the first half-year of 2023

“During the second quarter, we have continued to work methodically on our and our portfolio companies' prioritised issues. As a result, several of the portfolio companies have successfully raised capital, which is of great importance for their development plans. Although the acquisition rate has generally been lower in our Operational Groups, we have still been able to add a number of promising companies to these groups.” - Saeid Esmaeilzadeh, Chief Executive Officer Financial overview · Total net asset value was MSEK 7,893 (7,654), equivalent to SEK 10,240 per share (10,097). ·

Alexion enters gene therapy agreement with Pfizer

28 July 2023 Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies Agreement furthers Alexion's ambition to transform patient outcomes with genomic medicine and provides synergistic opportunities across AstraZeneca Portfolio includes preclinical gene therapy programmes and enabling technologies with potential across several therapeutic areas Alexion, AstraZeneca Rare Disease, today announced that it has entered a definitive purchase and licence agreement for a portfolio of preclinical gene therapy

A drop in the nickel sulphate market in China decreased Terrafame's operating result while basic production remained at a good level

The financial information presented about Terrafame Ltd in this release consists of unaudited FAS figures. The figures in brackets refer to the corresponding period of the previous year unless otherwise stated. April−June 2023 in brief: · Net sales from the battery chemicals business operations decreased to EUR 32.1 (53.4) million, or around 35% of the company’s total net sales. The decline was due to a significant drop in the nickel sulphate market in China, which resulted in Terrafame's decision to stop production at its battery chemicals plant in June–July. · Net sales from

Optomed’s January-June 2023 half year report will be published on 4 August 2023

Optomed Plc Press Release 28 July 2023 at 9.00, Helsinki Optomed’s January-June 2023 half year report will be published on 4 August 2023 Optomed will publish its January-June 2023 half year report on 4 August 2023 approximately at 9.00 EEST.   A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EEST/10.00 CET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EEST at the latest.   The participants are requested to register for the call in advance by email to

Final Results for the year to 31 January 2023

28 July 2023 LIMITLESS EARTH PLC ("Limitless" or the "Company") Final Results for the year to 31 January 2023 The Company announces its final results for the year to 31 January 2023. The Annual Report and Accounts for the year ended 31 January 2023 will shortly be posted to shareholders and uploaded to the Company’s website: www.limitlessearthplc.com. This announcement contains inside information for the purposes of UK Market Abuse Regulation. The Directors of the Company take responsibility for this announcement. For further information, please contact: Limitless

interim report 2023, January to June

17 percent net operating income growth, like-for-likeRental income was EUR 163 million,an increase of 16.8 percent compared to the same period last year.4.7 percentage points are related to changes in the property portfolio.The like-for-like rental income growth was 12.1 percent,due to growth in new lease levels and higher occupancy level.The like-for-like vacancy rate decreased by 2.9 percentage points during the last twelve months,mainly as a result of finished capital projects and strong demand for apartments.Vacancy rate at the end of the quarter was 6.9 percent where 84

Hoist Finance interim report Q2 2023

”The second quarter was a strong quarter for Hoist Finance. We more than doubled our adjusted earnings before tax and we are closing in on our RoE target of 15 per cent. At the same time we continue to address our cost base with the last push of the rejuvenation programme. With the lowest funding costs in the industry, a competitive business model and a robust capital base we are well equipped to seize the opportunities that the market and a reshaping industry provides”, says Harry Vranjes, CEO at Hoist Finance. Key highlights · Profit before tax amounted to SEK 178m and adjusted

Continued strong growth – EBITDA increased by 46 percent

SECOND QUARTER APRIL–JUNE            · The Group’s net sales amounted to SEK 386.1 (284.1) million, an increase of 36 percent. · The Group’s EBITDA was SEK 86.6 (59.4) million, an increase of 46 percent. · The EBITDA margin was 22 (21) percent. · Profit after tax amounted to SEK 46.8 (21.1) million. · Earnings per share amounted to SEK 3.2 (1.4). · Cash flow from operating activities was SEK 39.7 (24.4) million. HALF-YEAR JANUARY–JUNE · The Group’s net sales amounted to SEK 766.3 (546.9) million, an increase of 40 percent. · The Group’s EBITDA was SEK 146.0 (

BPEA EQT to acquire a majority stake in Indira IVF – India’s largest chain of fertility clinics

· BPEA EQT to acquire a majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, having facilitated 125,000 successful pregnancies to date · India is one of the fastest growing markets globally for Assisted Reproductive Technology  services due to its large addressable population, rising education levels and marriage age, declining fertility rates, and low market penetration  · BPEA EQT will invest in Indira IVF’s R&D capabilities and technology, while further broadening its footprint across India and

Lundin Mining Announces Closing of $800 Million Term Loan with Additional $400 Million Accordion Available

TORONTO, July 27, 2023 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) is pleased to announce the closing of a three-year term loan (“Term Loan”) in a principal amount of $800 million, with an additional $400 million accordion becoming available upon receipt of additional binding commitments and closing of up to an additional nineteen (19%) interest in SCM Minera Lumina Copper Chile (“Lumina Copper”) and satisfaction of relevant conditions precedent.  The Company has used the Term Loan to refinance the drawdown under the existing

DanCann Pharma A/S Completes Issuance of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 27 July 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, has today, on 27 July 2023, issued a total of 2,213,437 new shares of nominally DKK 0.0375 each by conversion of debt in the total amount of DKK 500,000 under the instrument issued as of 13 July 2023.As set out in press release published on 17 July 2023, the Company has issued a total of 378 convertible debt instruments, each of an amount of DKK 50,000, equal to an aggregate amount of DKK 18,900,000, and 8,190,000 warrants to

Capital increase in Impero A/S in connection with exercise of warrants

Company Announcement No. 9-2023 Copenhagen, 27 July 2023 Impero A/S announces today that Impero A/S’ share capital is increased by nominally DKK 1,000 as a result of exercise of warrants issued under the company’s warrant program. The capital increase is effected without pre-emptive rights for Impero A/S’ existing shareholders or others. The shares are subscribed in cash at a subscription price of DKK 3.30 per share of nominally DKK 0.10. The total proceeds for Impero A/S amount to DKK 33,000. The new shares correspond to approximately 0.05% of Impero A/S’ share capital prior

There are no items matching the current filter
There are no more items matching the current filter
Back to top